The Ministry of Health has conditionally approved the use of Hayat-Vax vaccine, which is the 7th Covid-19 vaccine that the country has licensed for emergency use.
This vaccine is produced by the Beijing Institute of Biological Products of China National Biotec Corporation, and packaged and shipped by the UAE. It is China's Sinopharm vaccine and technology transferred and packaged in the UAE.
The Vietnamese Ministry of Health granted the license based on the import company's request and the safety, quality and effectiveness data provided by the company up to September 3.
The Ministry of Health has asked the Drug Administration of Vietnam to grant an import license for Hayat-Vax vaccine according to regulations upon receiving the dossier of the importer.
The Department of Science, Technology and Training is responsible for selecting a qualified agency to evaluate the safety and effectiveness of the vaccine based on the advice of the Advisory Council on the use of vaccines and medical biological products of the Ministry of Health.
The Department of Preventive Medicine is responsible for receiving, storing, distributing and using the vaccine. The National Institute for Testing of Vaccines and Medical Biologicals is responsible for testing and issuing the certificate for the batch of Hayat-Vax vaccine before it is put into use.
The vaccine importing company must coordinate with the Ministry of Health to manage the risks of Hayat-Vax vaccine during its circulation in Vietnam.
This is the 7th Covid-19 vaccine licensed by the Ministry of Health, after AstraZeneca, Sputnik V, Sinopharm, Pfizer, Moderna and Johnson & Johnson.
As of September 10, Vietnam has received about 30 million doses of Covid-19 vaccine, of which 26 million have been administered.
The Prime Minister has requested the Ministry of Health and the Ministry of Foreign Affairs to appraise and approve the Hayat-Vax COVID-19 vaccine produced by the United Arab Emirates (UAE) for emergency use in Vietnam.